These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 5450639)

  • 1. Rifampin, new hope in the fight against tuberculosis.
    Koch-Weser D
    N Engl J Med; 1970 Sep; 283(12):655-6. PubMed ID: 5450639
    [No Abstract]   [Full Text] [Related]  

  • 2. Rifampin--a major new chemotherapeutic agent for the treatment of tuberculosis.
    Daniel TM
    N Engl J Med; 1969 Mar; 280(11):615-6. PubMed ID: 4974534
    [No Abstract]   [Full Text] [Related]  

  • 3. The efficacy of short-course chemotherapy for tuberculosis.
    Grosset J
    Bull Pan Am Health Organ; 1980; 14(2):139-49. PubMed ID: 6774794
    [No Abstract]   [Full Text] [Related]  

  • 4. The suitability of new drugs for intermittent chemotherapy of tuberculosis. An experimental study.
    Dickinson JM
    Scand J Respir Dis Suppl; 1969; 69():91-8. PubMed ID: 4190279
    [No Abstract]   [Full Text] [Related]  

  • 5. Three-in-one TB drug approved.
    Posit Aware; 1995; ():5. PubMed ID: 11362378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial: Rifampin in the treatment of tuberculosis.
    Grzybowshi S
    Can Med Assoc J; 1974 May; 110(9):1002 passim. PubMed ID: 4823101
    [No Abstract]   [Full Text] [Related]  

  • 7. [Indications, dosage and combinations of the major antitubercular drugs].
    Lebeau B; Rochemaure J
    Rev Prat; 1979 Jun; 29(33):2653-65. PubMed ID: 482818
    [No Abstract]   [Full Text] [Related]  

  • 8. Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.
    Page KR; Sifakis F; Montes de Oca R; Cronin WA; Doherty MC; Federline L; Bur S; Walsh T; Karney W; Milman J; Baruch N; Adelakun A; Dorman SE
    Arch Intern Med; 2006 Sep; 166(17):1863-70. PubMed ID: 17000943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A new and powerful anti-tubercular drug: rifampicin].
    Chenebault J
    Maroc Med; 1970 Jul; 537():465-70. PubMed ID: 5503096
    [No Abstract]   [Full Text] [Related]  

  • 10. [A new and powerful anti-tubercular drug: rifampicin].
    Chenebault J
    Voen Med Zh; 1970 Aug; 8():465-70. PubMed ID: 5515347
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of isoniazid and rifampicin regimens on the liver of tuberculosis patients].
    Pilheu JA; De Salvo MC; Barcat JA
    Medicina (B Aires); 1979; 39(3):298-304. PubMed ID: 514051
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-tuberculosis 4FDC tablets--mystery to chemistry.
    Dekker TG; Lötter AP
    Int J Tuberc Lung Dis; 2003 Mar; 7(3):205-6. PubMed ID: 12661831
    [No Abstract]   [Full Text] [Related]  

  • 13. Isoniazid and rifampin therapy for tuberculosis: what patients need to know.
    Wilson BA
    Medsurg Nurs; 1993 Jun; 2(3):236-7. PubMed ID: 8324584
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of experimental tuberculosis in guinea pigs by continuous and intermittent regimen with special reference to ethambutol and rifampicin].
    Westfal I; Wiza J; Rudnicka M; Szymaczek-Meyer L
    Gruzlica; 1973 Jan; 41(1):1-8. PubMed ID: 4686876
    [No Abstract]   [Full Text] [Related]  

  • 15. The effectiveness of a 9-month regimen of isoniazid alone versus 3- and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study.
    Spyridis NP; Spyridis PG; Gelesme A; Sypsa V; Valianatou M; Metsou F; Gourgiotis D; Tsolia MN
    Clin Infect Dis; 2007 Sep; 45(6):715-22. PubMed ID: 17712755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Modern view on drug therapy of tuberculosis].
    Douma J
    Ned Tijdschr Geneeskd; 1972 Oct; 116(41):1864-5. PubMed ID: 4640232
    [No Abstract]   [Full Text] [Related]  

  • 17. [Recommendations for the therapy of tuberculosis. (Position: December, 1988)].
    Merkel S; Fischer P; Weinecke W
    Z Erkr Atmungsorgane; 1989; 173(1):87-96. PubMed ID: 2800620
    [No Abstract]   [Full Text] [Related]  

  • 18. Drugs for tuberculosis.
    Med Lett Drugs Ther; 1995 Aug; 37(954):67-70. PubMed ID: 7616907
    [No Abstract]   [Full Text] [Related]  

  • 19. 4 months of rifampin compared with 9 months of isoniazid for the management of latent tuberculosis infection: a meta-analysis and cost-effectiveness study that focuses on compliance and liver toxicity.
    Ziakas PD; Mylonakis E
    Clin Infect Dis; 2009 Dec; 49(12):1883-9. PubMed ID: 19911936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Durable character of the sterilization of experimental tuberculosis in mice by rifampicin-isoniazid association: cortisone test].
    Grumbach F; Canetti G; Le Lirzin M
    Rev Tuberc Pneumol (Paris); 1970 Mar; 34(2):312-9. PubMed ID: 4994882
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.